Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | PLA2G4B | P0C869 | 4/20 | 0.44 |
| ▸ | RARB | P10826 | 3/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.40 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.40 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12804020 | 1.00 | TP53 (0.45) | TP53TSHRPLA2G4BRARBNAAA | |
| SCHEMBL28023365 | 1.00 | TP53 (0.45) | TP53TSHRPLA2G4BRARBNAAA | |
| SCHEMBL689136 | 1.00 | TP53 (0.45) | TP53TSHRPLA2G4BRARBNAAA | |
| SCHEMBL28023410 | 1.00 | TP53 (0.45) | TP53TSHRPLA2G4BRARBNAAA | |
| SCHEMBL17023984 | 0.94 | TP53 (0.42) | TP53TSHRPLA2G4BRARBNAAA | |
| SCHEMBL17023982 | 0.94 | TP53 (0.42) | TP53TSHRPLA2G4BRARBNAAA | |
| SCHEMBL3284825 | 0.90 | ALDH1A1 (0.40) | TP53TSHRPLA2G4BRARB | |
| SCHEMBL3287748 | 0.89 | ALDH1A1 (0.39) | TP53TSHRPLA2G4BRARB | |
| SCHEMBL20820038 | 0.88 | SMPD1 (0.40) | TP53TSHRPLA2G4BS1PR4S1PR1 | |
| SCHEMBL165416 | 0.87 | MEN1 (0.40) | TSHRCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2136779-B1 | HIGH SHINE, STICK-SHAPED COSMETIC PRODUCTS | ELC MAN LLC (US) | 2021-09-29 | — | — | EP | claimed |
| EP-3196267-B1 | URETHANE-BASED PRESSURE-SENSITIVE ADHESIVE | COSMED PHARMACEUTICAL CO LTD (JP) | 2020-07-29 | — | — | EP | claimed |
| EP-1132075-B1 | Coated cosmetic powder | INTERCOS ITALIANA (IT) | 2012-07-18 | — | — | EP | claimed |
| EP-1466586-B1 | Water-in-oil emulsion preparation for external use on skin | NISSHIN OILLIO GROUP LTD (JP) | 2011-10-12 | — | — | EP | claimed |
| EP-2217206-A2 | TRANSDERMAL THERAPEUTIC SYSTEM HAVING A CONTENT OF A MODULATOR FOR NICOTINIC ACETYLCHOLINE RECEPTORS (NACHR) | Acino AG (DE) | 2010-08-18 | — | — | EP | claimed |
| WO-2009071326-A2 | TRANSDERMAL THERAPEUTIC SYSTEM HAVING A CONTENT OF A MODULATOR FOR NICOTINIC ACETYLCHOLINE RECEPTORS (NACHR) | ACINO AG (DE) | 2009-06-11 | — | — | WO | claimed |
| EP-0904772-B1 | SKIN COLOR IMPROVER | KAO CORP (JP) | 2003-09-24 | — | — | EP | claimed |
| EP-0713385-B1 | CLEANSING COMPOSITIONS CONTAINING AN ALKANOATE AS CONDITIONER | UNILEVER PLC (GB) | 1999-03-24 | — | — | EP | claimed |
| US-20240358860-A1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | THE GENERAL HOSPITAL CORPORATION (US) | 2024-10-31 | — | — | US | disclosed |
| US-12059481-B2 | Compounds, systems, and methods for monitoring and treating a surface of a subject | THE GENERAL HOSPITAL CORPORATION (US) | 2024-08-13 | — | — | US | disclosed |
| EP-2872877-B1 | SYSTEM AND METHOD FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | MASSACHUSETTS GEN HOSPITAL (US) | 2023-05-24 | — | — | EP | disclosed |
| EP-3443951-B1 | SUPERFATTING AGENT AND PERSONAL CARE COMPOSITION | SABO SPA (IT) | 2022-09-21 | — | — | EP | disclosed |
| US-20220257797-A1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | THE GENERAL HOSPITAL CORPORATION | 2022-08-18 | — | — | US | disclosed |
| US-11253613-B2 | Compounds, systems, and methods for monitoring and treating a surface of a subject | THE GENERAL HOSPITAL CORPORATION (US) | 2022-02-22 | — | — | US | disclosed |
| EP-2559427-A1 | Transdermal therapeutic system having a content of a modulator for nicotinic acetylcholine receptors (nAChR) | Acino AG (DE) | 2013-02-20 | — | — | EP | disclosed |
| EP-2217206-B1 | TRANSDERMAL THERAPEUTIC SYSTEM HAVING A CONTENT OF A MODULATOR FOR NICOTINIC ACETYLCHOLINE RECEPTORS (NACHR) | ACINO AG (DE) | 2012-10-24 | — | — | EP | disclosed |
| EP-2217206-A2 | TRANSDERMAL THERAPEUTIC SYSTEM HAVING A CONTENT OF A MODULATOR FOR NICOTINIC ACETYLCHOLINE RECEPTORS (NACHR) | Acino AG (DE) | 2010-08-18 | — | — | EP | disclosed |
| EP-1660025-B1 | COSMETIC COMPOSITION CONTAINING A POLYOXYETHYL COMBINATION AND A LIPOPEPTIDE | SHOWA DENKO KK (JP) | 2009-07-15 | — | — | EP | disclosed |
| WO-2009071326-A2 | TRANSDERMAL THERAPEUTIC SYSTEM HAVING A CONTENT OF A MODULATOR FOR NICOTINIC ACETYLCHOLINE RECEPTORS (NACHR) | ACINO AG (DE) | 2009-06-11 | — | — | WO | disclosed |
| US-6660253-B2 | Powder phase, binder phase, water phase, and an absorbing polymer chosen so that said make-up product, after drying, has a given specific weight range; can be applied without applicator | INTERCOS ITALIA S.P.A. (IT) | 2003-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11253613-B2 | Compounds, systems, and methods for monitoring and treating a surface of a subject | PPOX, HMOX2, HMBS | TP53 1773/4885TSHR 4653/4885PLA2G4B 2408/4885 |
| US-12059481-B2 | Compounds, systems, and methods for monitoring and treating a surface of a subject | PPOX, HMOX2, HMOX1 | TP53 1936/4885TSHR 4788/4885PLA2G4B 1665/4885 |
| US-20220257797-A1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | PPOX, HMOX2, HMOX1 | TP53 1936/4885TSHR 4788/4885PLA2G4B 1665/4885 |
| US-20240358860-A1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | PPOX, HMOX2, HMOX1 | TP53 1936/4885TSHR 4788/4885PLA2G4B 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.